Charles Bobrinskoy
Ariel Focus Fund
Charles Bobrinskoy Johnson & Johnson stake
total: 58
Ariel Focus Fund JNJ trades
- Total transactions:
- 14
- New positions:
- 1
- Added:
- 6
- Reduced:
- 7
- Held since:
- 2019 Q3
- Held for:
- 27 quarters
- Latest activity:
- 2026 Q1
According to 2026 Q1 report, Charles Bobrinskoy holds 17,965 Johnson & Johnson (JNJ) shares with a market value of roughly $4.39M accounting for 5.41% of the overall portfolio. To date, the estimated cost basis is nearly $153.61 for "buy" trades and estimated average "sell" price is $182.28. Ariel Focus Fund first purchased JNJ in 2019 Q3, initially acquiring 13,300 shares. Since the initial investment in Johnson & Johnson (JNJ), Ariel Focus Fund has made 13 more transactions.
When did Charles Bobrinskoy buy Johnson & Johnson (JNJ)?
Charles Bobrinskoy first invested in Johnson & Johnson (JNJ) in 2019 Q3 at the reported quarter-end price of $129.38 per share.
What's the cost basis of Ariel Focus Fund's JNJ stake?
The estimated cost basis for Johnson & Johnson (JNJ) stake is around $153.61 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $153.60
- Weighted AVG sell price:
- $182.28
Charles Bobrinskoy's historical trades in Johnson & Johnson
14 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
5.41%
|
17,965
|
$244.44
|
$4,391,365
|
-8.69% (-1,709)
|
-0.55%
|
|
2025 Q4
|
5.40%
|
19,674
|
$206.95
|
$4,071,534
|
-17.48% (-4,168)
|
-1.11%
|
|
2025 Q3
|
5.69%
|
23,842
|
$185.42
|
$4,420,784
|
+66.90% (+9,557)
|
+2.28%
|
|
2024 Q4
|
3.07%
|
14,285
|
$144.62
|
$2,065,897
|
+19.68% (+2,349)
|
+0.5%
|
|
2024 Q2
|
2.68%
|
11,936
|
$146.16
|
$1,744,566
|
-5.51% (-696)
|
-0.14%
|
|
2023 Q3
|
3.20%
|
12,632
|
$155.75
|
$1,967,434
|
-17.42% (-2,665)
|
-0.63%
|
|
2023 Q1
|
3.60%
|
15,297
|
$155.00
|
$2,371,035
|
+10.12% (+1,406)
|
+0.33%
|
|
2021 Q4
|
3.35%
|
13,891
|
$171.07
|
$2,376,333
|
+9.91% (+1,253)
|
+0.3%
|
|
2021 Q3
|
3.32%
|
12,638
|
$161.50
|
$2,041,037
|
-3.16% (-412)
|
-0.1%
|
|
2021 Q2
|
3.22%
|
13,050
|
$164.74
|
$2,149,857
|
+16.00% (+1,800)
|
+0.44%
|
|
2020 Q3
|
3.76%
|
$148.88
|
-5.86% (-700)
|
|||
|
2020 Q2
|
3.66%
|
$140.63
|
-14.03% (-1,950)
|
|||
|
2019 Q4
|
3.25%
|
$145.87
|
+4.51% (+600)
|
|||
|
2019 Q3
|
3.06%
|
$129.38
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.